IMGN : Analysis & Opinions
May 20, 2015These cancer research stocks offer both a high ceiling and the potential to save lives.
April 2, 2015Following the approval of weight control management drug Belviq by the Food and Drug Administration in 2012, Arena Pharmaceuticals ...
August 27, 2012The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed 0.1%. ...
August 27, 2010Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.